What are the therapy options for follicular lymphoma (FL) following second-line treatment?

Updated: Jan 16, 2019
  • Author: Francisco J Hernandez-Ilizaliturri, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print
Answer

Answer

Therapeutic options following second-line treatment are as follows:

  • Observation
  • Rituximab 375 mg/m 2 IV every 8 wk for four additional doses [16] or
  • Rituximab 375 mg/m 2 IV weekly for 4 wk every 6 mo for 2 y [17] or
  • Rituximab 375 mg/m 2 IV weekly for 4 wk every 3 mo and 6 mo following completion of reinduction therapy [18] or
  • Rituximab 375 mg/m 2 IV every 3 mo for 2 y [19]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!